Skip to main content

Advertisement

Log in

Epstein–Barr virus-associated T/NK cell-type central nervous system lymphoma which manifested as a post-transplantation lymphoproliferative disorder in a renal transplant recipient

  • Letter to the editor
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

A 31-year-old male, who had received a cadaveric renal allograft in April 2003, consulted a clinic for a transient hemiplegia in August 2004. At that time, a course observation without medication was chosen. In October 2004, he was admitted to our hospital by ambulance with a clonic seizure and a recurrence of hemiplegia on the right side of his body. Head magnetic resonance imaging (MRI) showed enhanced multifocal nodular lesions with remarkable cerebral edema mainly in the left frontal lobe. A stereotactic brain biopsy was performed, and the pathological diagnosis was nasal type extranodal T/NK cell lymphoma manifested as the post transplant lymphoproliferative disease (PTLD). Systemic staging workups showed no extra-CNS involvement. Because of his renal dysfunction and no sign of any extra-CNS involvement, a reduction of the immunosuppressants and whole brain radiation therapy (WBRT) (40 Gy) without chemotherapy were applied to his therapeutic regimen. After WBRT, MRI showed a remarkable reduction in the number and size of the tumors, and no neurological abnormalities were physically observed. As of December 2006, no sign of recurrence has subsequently been found in both the intra- and extra-CNS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Mukai HY, Kojima H, Suzukawa K et al (2000) Nasal natural killer cel lymphoma in a post-ranal transplant patient. Transplantation 69:1501–1503

    Article  PubMed  CAS  Google Scholar 

  2. Nalesnik MA (2001) The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach. Transpl Infect Dis 3:88–96

    Article  PubMed  CAS  Google Scholar 

  3. Leblond V, Davi F, Charlotte F et al (1998) Posttransplant lymphoproliferative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol 16:2052–2059

    PubMed  CAS  Google Scholar 

  4. Hsi ED, Picken MM, Alkan S (1998) Post-transplantation lymphoproliferative disorder of the NK-cell type: a case report and view of the literature. Mod Pathol 11:479–484

    PubMed  CAS  Google Scholar 

  5. Kwong YL, Lam CC, Chan TM (2000) Post-transplantation lymphoproliferative disease of natural killer cell lineage: a clinicopathological and molecular analysis. Br J Haematol 10:197–202

    Article  Google Scholar 

  6. Gijtenbeek JMM, Rosenblum MK, DeAngelis LM (2001) Primary central nervous system T-cell lymphoma. Neurology 57:716–718

    PubMed  CAS  Google Scholar 

  7. DeAngelis LM, Hormigo A (2004) Treatment of primary central nervous system lymphoma. Semin Oncol 31:684–692

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nobuhiko Omori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Omori, N., Narai, H., Tanaka, T. et al. Epstein–Barr virus-associated T/NK cell-type central nervous system lymphoma which manifested as a post-transplantation lymphoproliferative disorder in a renal transplant recipient. J Neurooncol 87, 189–191 (2008). https://doi.org/10.1007/s11060-007-9504-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-007-9504-2

Keywords

Navigation